Tasker Capital

Tasker Capital, formerly known as Tasker Products Corp, was a biotechnology company specializing in the development and commercialization of antimicrobial technologies. The company's primary asset was a proprietary acidified sulfate technology, often referred to as "Tasker Blue," which utilized a low-pH mechanism to effectively neutralize a broad spectrum of pathogens. Tasker targeted several key markets, including food safety for poultry and meat processing, as well as sanitization solutions for the healthcare and consumer sectors. Despite achieving commercial-stage status with its antimicrobial products, the company faced financial challenges and eventually became inactive. Its technology was designed to provide a safer, non-toxic alternative to traditional chemical disinfectants.